4th Quarter - Report

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership agreement, with respect to data exclusivity for biologics.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO).

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Health Issues HCR

H.R. 6: 21st Century Cures Act. H.R. 3537: Synthetic Drug Control Act of 2015. H.R. 1786: "James Zadroga 9/11 Health and Compensation Reauthorization Act" with respect to potential budgetary offsets.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1786 (114th), H.R. 3537 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

P.L. 114-74, "Bipartisan Budget Act of 2015".

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.